Lanzamiento Enero 2027

Ensayo controlado aleatorizado2002

Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine

Wesensten NJ, Belenky G, Kautz MA, Thorne DR, Reichardt RM, Balkin TJ

Psychopharmacology · 135 citas

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación independiente
Gobierno
U.S. Department of Defense
Gobierno
U.S. Army Materiel Command
Gobierno
U.S. Army Medical Command
Gobierno
Medical Research and Materiel Command

Según 4 financiadores declarados.

Publicación

Publicado
2001-10-19 · Psychopharmacology (Berl) · vol. 159 · número 3 · págs. 238–247
Editorial
Springer Science+Business Media
Citado
404 citas · más que el 99% de estudios similares · 15.7× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
26 trabajos
Acceso
De pago
Áreas de investigación
Sleep and Work-Related Fatigue · Coffee research and impacts · Sleep and Wakefulness Research
Palabras clave
modafinil, caffeine, sleep deprivation, alertness, cognitive performance, circadian rhythm, dose-response relationship, stimulants, healthy young adults
MeSH
humans, sleep deprivation, benzhydryl compounds, caffeine, central nervous system stimulants, body temperature, administration, oral, analysis of variance, double-blind method, cognition, psychomotor performance, wakefulness, reaction time, sleep stages, circadian rhythm, dose-response relationship, drug, adolescent, adult, female, male, modafinil

6 autores

  • Nancy Jo Wesensten🇺🇸Walter Reed Army Institute of Research
  • Gregory Lucas Belenky🇺🇸Walter Reed Army Institute of Research
  • Mary A. Kautz🇺🇸Walter Reed Army Institute of Research
  • David R. Thorne🇺🇸Walter Reed Army Institute of Research
  • Rebecca M. Reichardt🇺🇸Walter Reed Army Institute of Research
  • Thomas J. Balkin🇺🇸Walter Reed Army Institute of Research

Resumen

El texto original del estudio, en el idioma en que se publicó.

Rationale

The performance and alertness effects of modafinil were evaluated to determine whether modafinil should replace caffeine for restoring performance and alertness during total sleep deprivation in otherwise healthy adults.

Objectives

Study objectives were to determine (a) the relative efficacy of three doses of modafinil versus an active control dose of caffeine 600 mg; (b) whether modafinil effects are dose-dependent; and (c) the extent to which both agents maintain performance and alertness during the circadian trough.

Methods

Fifty healthy young adults remained awake for 54.5 h (from 6:30 a.m. day 1 to 1:00 p.m. on day 3) and performance and alertness tests were administered bi-hourly from 8:00 a.m. day 1 until 10:00 p.m. day 2. At 11:55 p.m. on day 2 (after 41.5 h awake), subjects received double blind administration of one of five drug doses: placebo; modafinil 100, 200, or 400 mg; or caffeine 600 mg ( n=10 per group), followed by hourly testing from midnight through 12:00 p.m. on day 3.

Results

Performance and alertness were significantly improved by modafinil 200 and 400 mg relative to placebo, and effects were comparable to those obtained with caffeine 600 mg. Although a trend toward better performance at higher modafinil doses suggested a dose-dependent effect, differences between modafinil doses were not significant. Performance enhancing effects were especially salient during the circadian nadir (6:00 a.m. through 10:00 a.m.). Few instances of adverse subjective side effects (nausea, heart pounding) were reported.

Conclusions

Like caffeine, modafinil maintained performance and alertness during the early morning hours, when the combined effects of sleep loss and the circadian trough of performance and alertness trough were manifest. Thus, equivalent performance- and alertness-enhancing effects were obtained with drugs possessing different mechanisms of action. However, modafinil does not appear to offer advantages over caffeine (which is more readily available and less expensive) for improving performance and alertness during sleep loss in otherwise normal, healthy adults.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.